BR0314781A - Composição de polìmero e formas de dosagem compreendendo a mesma - Google Patents
Composição de polìmero e formas de dosagem compreendendo a mesmaInfo
- Publication number
- BR0314781A BR0314781A BR0314781-9A BR0314781A BR0314781A BR 0314781 A BR0314781 A BR 0314781A BR 0314781 A BR0314781 A BR 0314781A BR 0314781 A BR0314781 A BR 0314781A
- Authority
- BR
- Brazil
- Prior art keywords
- same
- dosage forms
- polymer composition
- composition
- dosage form
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSIçãO DE POLìMERO E FORMAS DE DOSAGEM COMPREENDENDO A MESMA". é fornecida uma composição compreendendo um polímero solúvel em água de peso molecular elevado, tendo um ponto de turvamento de cerca de 20 a cerca de 90<198>C e um polímero de gelificação. A composição pode ser empregada como um componente de uma forma de dosagem farmacêutica, tal como a casca de uma forma de dosagem, ou como uma matriz comestível, isto é, uma forma de dosagem farmacêutica de per si.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2003/008960 WO2004028514A1 (en) | 2002-09-28 | 2003-03-21 | Polymer composition and dosage forms comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0314781A true BR0314781A (pt) | 2005-07-26 |
Family
ID=34271652
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314777-0A BR0314777A (pt) | 2002-09-28 | 2003-03-21 | Formas de dosagem de liberação modificada |
BR0314781-9A BR0314781A (pt) | 2002-09-28 | 2003-03-21 | Composição de polìmero e formas de dosagem compreendendo a mesma |
BR0314787-8A BR0314787A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem de liberação modificada |
BR0314804-1A BR0314804A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem de liberação modificada |
BR0314547-6A BR0314547A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314777-0A BR0314777A (pt) | 2002-09-28 | 2003-03-21 | Formas de dosagem de liberação modificada |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314787-8A BR0314787A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem de liberação modificada |
BR0314804-1A BR0314804A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem de liberação modificada |
BR0314547-6A BR0314547A (pt) | 2002-09-28 | 2003-03-21 | Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo |
Country Status (8)
Country | Link |
---|---|
JP (3) | JP2006517514A (pt) |
CN (3) | CN1700908A (pt) |
AT (1) | ATE444739T1 (pt) |
AU (4) | AU2003220472A1 (pt) |
BR (5) | BR0314777A (pt) |
CA (3) | CA2500313C (pt) |
DE (2) | DE60329614D1 (pt) |
MX (1) | MXPA05003283A (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2470463C (en) | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
US20110195121A1 (en) * | 2008-06-19 | 2011-08-11 | Seshni Sewlall | chronotherapeutic pharmaceutical dosage form |
JPWO2011118454A1 (ja) * | 2010-03-23 | 2013-07-04 | リンテック株式会社 | 固形製剤 |
US9693957B2 (en) * | 2011-07-08 | 2017-07-04 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
EP2811985B1 (en) * | 2012-02-07 | 2018-10-17 | Johnson & Johnson Consumer Inc. | Rapidly disintegrating coated tablets |
TW201400146A (zh) * | 2012-06-05 | 2014-01-01 | Takeda Pharmaceutical | 有核錠 |
EP3193845A1 (en) * | 2014-09-19 | 2017-07-26 | The Procter and Gamble Company | Pulsed release phenylephrine dosage forms |
EP3731821A1 (en) * | 2017-12-29 | 2020-11-04 | Laxxon Medical AG | Drug delivery system |
AU2022320730A1 (en) * | 2021-07-30 | 2024-03-14 | Evecxia Therapeutics, Inc. | 5-hydroxytryptophan gastroretentive dosage forms |
CN115295864B (zh) * | 2021-11-09 | 2023-08-11 | 深圳市德方创域新能源科技有限公司 | 正极补锂添加剂及其制备方法与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007470A1 (en) * | 1992-09-30 | 1994-04-14 | Pfizer Inc. | Article containing a core and a coating having a non constant thickness |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
IT1282576B1 (it) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
WO2001078681A1 (fr) * | 2000-04-17 | 2001-10-25 | Yamanouchi Pharmaceutical Co., Ltd. | Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant |
JP2004518708A (ja) * | 2001-02-13 | 2004-06-24 | アストラゼネカ・アクチエボラーグ | 放出性が改良された新規な処方物 |
-
2003
- 2003-03-21 AT AT03714356T patent/ATE444739T1/de not_active IP Right Cessation
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/pt not_active Application Discontinuation
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/zh active Pending
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/pt not_active Application Discontinuation
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/pt not_active IP Right Cessation
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/zh active Pending
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/zh active Pending
- 2003-03-21 DE DE60329614T patent/DE60329614D1/de not_active Expired - Lifetime
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/ja active Pending
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/ja active Pending
- 2003-03-21 DE DE60335270T patent/DE60335270D1/de not_active Expired - Lifetime
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/pt not_active Application Discontinuation
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/ja active Pending
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/pt not_active Application Discontinuation
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/es unknown
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003220472A1 (en) | 2004-04-19 |
BR0314787A (pt) | 2005-07-26 |
CN1700908A (zh) | 2005-11-23 |
MXPA05003283A (es) | 2005-11-23 |
CA2500311A1 (en) | 2004-04-08 |
BR0314547A (pt) | 2005-08-09 |
CN1684671A (zh) | 2005-10-19 |
BR0314804A (pt) | 2005-08-02 |
CA2500312A1 (en) | 2004-04-08 |
JP2006517183A (ja) | 2006-07-20 |
BR0314777A (pt) | 2005-07-26 |
DE60329614D1 (de) | 2009-11-19 |
DE60335270D1 (de) | 2011-01-20 |
AU2003220466A1 (en) | 2004-04-19 |
JP2006517182A (ja) | 2006-07-20 |
AU2003225944A1 (en) | 2004-04-19 |
AU2003218359A1 (en) | 2004-04-19 |
ATE444739T1 (de) | 2009-10-15 |
JP2006517514A (ja) | 2006-07-27 |
CN1700907A (zh) | 2005-11-23 |
CA2500313A1 (en) | 2004-04-08 |
CA2500313C (en) | 2011-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE551988T1 (de) | Orale zusammensetzungen, ihre herstellung und verwendung | |
NO20051542L (no) | Farmasoytisk preparat | |
BR0314781A (pt) | Composição de polìmero e formas de dosagem compreendendo a mesma | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
CL2004000778A1 (es) | Compuestos derivados de heterociclos de 5 miembros, inhibidores de la porteina tirosina fosfatasa 1b (ptp1b); composiciones farmaceuticas, utiles para tratar hipertension, obesidad, diabetes, hiperlipidemia. | |
EA200700658A1 (ru) | Фармацевтическая композиция, представляющая собой твердую дисперсию с полимерной матрицей, содержащей непрерывную фазу полидекстрозы и непрерывную фазу полимера, не являющегося полидекстрозой | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
BRPI0511966A (pt) | composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons | |
CL2004000270A1 (es) | Compuestos derivados de pirazol, sus sales de adicion acidas,trastornos de vih y virus geneticamente relacionados. hidratos, solvatos; composiciones farmaceuticas; y su uso en el tramiento de trastornos del vih y virus geneticamente relacionados. | |
CL2004000590A1 (es) | Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v | |
RS20050066A (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
RS51271B (sr) | Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid | |
BR0316310A (pt) | Composições farmacêuticas tendo um veìculo modificado | |
TR200401793T4 (tr) | Perindopril tuzu ve bunu içeren farmasötik bileşimler. | |
UY29169A1 (es) | Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica | |
TW200637584A (en) | External skin agent for preventing inflammation | |
CL2003002611A1 (es) | Compuestos derivados del acido tiofeno hidroxamico, 2-hidroxamida-5-[(aril o heteroaril)-disutituido-metil]-amida del acido tiofeno-2,5-dicarboxilico enantiomeros, composicion farmaceutica, procedimiento de preparacion, y su uso para el tratamiento d | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
HUP0101374A2 (hu) | Szervetlen nitritet és szerves savat tartalmazó helyi vírusellenes készítmény | |
GB2421241A (en) | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof | |
TW200630121A (en) | Immediate release film coating | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
IS7492A (is) | Lyfjablöndu uppskriftir, sem innifela melantónín |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |